65. Supporting science in normal times
Remember
normality? That time before the pandemic, when we used to be able to hang out
in bars, visit our relatives and friends at will, go out as we pleased? Great
times. They were also the times when, as a society, we ignored the funding
needs of science. The media is full of stories of research groups who abandoned
successful research lines in coronavirus vaccines and treatments due to lack of
funding and no interest from pharmaceutical companies and institutions. The
former is logical, commercial companies don’t invest in treatments for
illnesses which are no longer a problem. But as a society, and through our
institutions, the focus should be different. However, national cuts in research
budgets are only vehemently opposed by scientists. The rest of citizens haven’t
cared. We should remember this in future, as the groups working on antibiotic
resistance, climate change reversal and diabetes control meet the same
challenges as those working on coronavirus vaccines did in the past
Length: 999 characters
Comments